TG THERAPEUTICS, INC. Quarterly Depreciation in USD from Q1 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tg Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2012 to Q1 2023.
  • Tg Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $68K, a 10.5% decline year-over-year.
  • Tg Therapeutics, Inc. annual Depreciation for 2022 was $303K, a 7.45% increase from 2021.
  • Tg Therapeutics, Inc. annual Depreciation for 2021 was $282K, a 78.5% increase from 2020.
  • Tg Therapeutics, Inc. annual Depreciation for 2020 was $158K, a 58% increase from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $68K -$8K -10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q1 2022 $76K +$17K +28.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $59K +$29K +96.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $30K +$7K +30.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $23K +$3K +15% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $20K $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $20K +$13.6K +213% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $6.38K +$3.96K +164% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $2.42K +$1.71K +243% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $706 +$591 +514% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $115 +$115 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.